Table 1.

Effects of CD437 on Cell Viability and Caspase Activation in Freshly Isolated APL Blasts

Time Treatment No. Viable Cells ×1,000 (% viability) DEVD-amc Hydrolytic Activity (Fluorescence Arbitrary Units)
Patient 1  
 16 h  Control  550 ± 85 8.3 ± 1.4  
  (97 ± 2)  
 CD437 490 ± 62  11.1 ± 2.0  
  (86 ± 6)  
 68 h Control  502 ± 120  6.3 ± 3.9 
  (72 ± 11)  
 CD437  160 ± 17* 72.0 ± 20.1* 
  (58 ± 9)  
Patient 2  
 16 h Control  360 ± 87  2.5 ± 1.8  
  (88 ± 3) 
 CD437  298 ± 26  10.7 ± 1.5* 
  (89 ± 2)  
 84 h  Control  324 ± 54 4.1 ± 1.0  
  (88 ± 2)  
 CD437 136 ± 18* 6.6 ± 1.3  
  (56 ± 2)* 
Time Treatment No. Viable Cells ×1,000 (% viability) DEVD-amc Hydrolytic Activity (Fluorescence Arbitrary Units)
Patient 1  
 16 h  Control  550 ± 85 8.3 ± 1.4  
  (97 ± 2)  
 CD437 490 ± 62  11.1 ± 2.0  
  (86 ± 6)  
 68 h Control  502 ± 120  6.3 ± 3.9 
  (72 ± 11)  
 CD437  160 ± 17* 72.0 ± 20.1* 
  (58 ± 9)  
Patient 2  
 16 h Control  360 ± 87  2.5 ± 1.8  
  (88 ± 3) 
 CD437  298 ± 26  10.7 ± 1.5* 
  (89 ± 2)  
 84 h  Control  324 ± 54 4.1 ± 1.0  
  (88 ± 2)  
 CD437 136 ± 18* 6.6 ± 1.3  
  (56 ± 2)* 

Cells (600,000/mL for patient 1 and 300,000/mL for patient 2) were treated for the indicated amount of time with CD437 (10−6mol/L). At the end of treatment, aliquots of the cultures were stained with erythrosin for the determination of the number of cells and their viability. Remaining cells were harvested, homogenized, and the extract was assayed for DEVD-amc hydrolytic activity. Each value represents the mean ± SD of three replicate cultures.

*

Statistically significant relative to control following the Student’st-test (P < .01).

Close Modal

or Create an Account

Close Modal
Close Modal